This presentation describes an investigation of the adoption of a new paediatric formulation of the antimalarial combination artemether-lumefantrine in 5 African countries, as an example of drug policy change in general. It was found that information did not always reach the appropriate people, and there was not always an effective process for policy change, adequate finance or a sufficiently well-organised health system. Recommendations are made for dealing with these problems and so improving uptake.
Presentation from Symposium 80: Child-friendly medicines for malaria: the challenge of accelerating the development of paediatric treatments, and of turning evidence into policy. Symposium held at American Society of Tropical Medicine and Hygiene 59th annual meeting, Atlanta, Georgia, USA, 5 November 2010. Medicines for Malaria Venture, Geneva, Switzerland; 22 pp.